Related Experiment Video
Updated: Aug 14, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
[Therapeutic targeting of Notch signaling in cancer]
Mehdi Brahmi1, Olivia Bally1, Lauriane Eberst1
1Centre Léon-Bérard, département de cancérologie médicale, 28, rue Laennec, 69373 Lyon cedex 08, France.
Abstract:
The Notch pathway plays an essential role during embryonal development and tissue in adults. Notch signaling occurs through transmembrane receptors which undergo several proteolytic cleavages that lead to the release of the Notch intracytoplasmic domain (NICD), which in turn activates the transcription of target genes. Oncogenic alterations of Notch receptors were first identified in T acute lymphoblastic leukemia and subsequently in solid tumors and other hematological malignancies. The important role of Notch signaling in cancer makes it an interesting target for drug development. Several classes of compounds targeting Notch signaling are currently in clinical development. However, the complexity of Notch signaling as well as its importance in tissue homeostasis makes the clinical development of these therapies more complex than anticipated. Additional clinical and preclinical investigations are needed to adequately target Notch signaling in cancer therapy.
Insights
The Notch pathway is crucial for development and cancer. Targeting it for cancer therapy is complex, requiring further research due to its role in normal tissue homeostasis.
Area of Science:
- Molecular Biology
- Cell Signaling
- Oncology
Background:
- The Notch pathway is vital for embryonic development and adult tissue maintenance.
- Notch signaling involves receptor cleavage, releasing the Notch intracytoplasmic domain (NICD) to regulate gene transcription.
- Aberrant Notch signaling is implicated in various cancers, including leukemia and solid tumors.
Purpose of the Study:
- To review the role of Notch signaling in cancer.
- To discuss the therapeutic potential of targeting Notch signaling in oncology.
- To highlight the challenges in developing Notch-targeted cancer therapies.
Main Methods:
- Literature review of Notch pathway function in development and cancer.
- Analysis of current clinical development of Notch inhibitors.
- Discussion of the complexities of Notch signaling in cancer therapy.
Main Results:
- Notch pathway alterations are common in various malignancies.
- Several Notch-targeting drug classes are in clinical trials.
- The dual role of Notch in cancer and homeostasis complicates therapeutic strategies.
Conclusions:
- Notch signaling is a significant target for cancer drug development.
- Clinical development of Notch inhibitors faces challenges due to pathway complexity and essential physiological roles.
- Further preclinical and clinical studies are necessary for effective Notch-targeted cancer therapy.
More Related Videos
05:48Cell Aggregation Assays to Evaluate the Binding of the Drosophila Notch with Trans-Ligands and its Inhibition by Cis-Ligands
Published on: January 2, 2018
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Non-Canonical Wnt Signaling Pathways
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...